Inhibition of FAO through Etomoxir should be explored for ERU-affected horses, as this successfully reversed the FAO-driven altered phenotype in CD4+ TRM cells in Crohn’s disease by reducing their inflammatory capacity and enhancing their apoptosis susceptibility [81]. The gene discussed is CD4; the disease is Crohn disease.